Core Viewpoint - Longevity Health Holdings, Inc. has announced a reverse stock split at a ratio of 1-for-30, which was approved by stockholders and is set to take effect on May 12, 2025 [1][2][3]. Group 1: Reverse Stock Split Details - The reverse stock split will reduce the number of outstanding shares from approximately 30.1 million to about 1 million shares [3]. - The effective time for the reverse stock split is set for May 12, 2025, with trading on a split-adjusted basis expected to begin on May 14, 2025 [2][3]. - No fractional shares will be issued; any fractional shares will be rounded up to the nearest whole share [4]. Group 2: Stockholder and Trading Information - Registered stockholders holding shares in book-entry form will not need to take action to receive post-split shares, while those in brokerage accounts will have their positions automatically adjusted [4]. - Proportional adjustments will be made to the number of shares issuable upon exercise of outstanding stock options and warrants, as well as the exercise prices [5]. Group 3: Company Overview - Longevity Health Holdings, Inc. focuses on bio-aesthetics, particularly in longevity and healthy aging, with product lines including Carmell Secretome™ and Elevai Exosomes™ [7]. - The company sells its products through business-to-business, direct-to-consumer, and distributor sales channels in the United States [7].